van den Heuvel-Eibrink MM - Search Results

1

A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia.

Hartman A, te Winkel ML, van Beek RD, de Muinck Keizer-Schrama SM, Kemper HC, Hop WC, van den Heuvel-Eibrink MM, Pieters R. Hartman A, et al. Pediatr Blood Cancer. 2009 Jul;53(1):64-71. doi: 10.1002/pbc.21942. Pediatr Blood Cancer. 2009. PMID: 19283791 Clinical Trial.

2

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.

van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PA, Pieters R, Schoester M, Löwenberg B, Sonneveld P. van den Heuvel-Eibrink MM, et al. Br J Haematol. 1997 Oct;99(1):76-83. doi: 10.1046/j.1365-2141.1997.3343148.x. Br J Haematol. 1997. PMID: 9359506 Free article.

3

Bone mineral density in children with acute lymphoblastic leukaemia.

Boot AM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM. Boot AM, et al. Eur J Cancer. 1999 Nov;35(12):1693-7. doi: 10.1016/s0959-8049(99)00143-4. Eur J Cancer. 1999. PMID: 10674015

4

The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia.

van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. van den Heuvel-Eibrink MM, et al. Int J Clin Pharmacol Ther. 2000 Mar;38(3):94-110. doi: 10.5414/cpp38094. Int J Clin Pharmacol Ther. 2000. PMID: 10739113 Review.

5

Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.

van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM. van der Sluis IM, et al. Med Pediatr Oncol. 2000 Oct;35(4):415-20. doi: 10.1002/1096-911x(20001001)35:4<415::aid-mpo4>3.0.co;2-9. Med Pediatr Oncol. 2000. PMID: 11025472

6

MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7.

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, Slater RM, Smit EM, van Noesel MM, van der Holt B, Schoester M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2001 Mar;15(3):398-405. doi: 10.1038/sj.leu.2402027. Leukemia. 2001. PMID: 11237063

7

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Kuijpers M, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2001 May;15(5):855-6. doi: 10.1038/sj.leu.2402112. Leukemia. 2001. PMID: 11368449 No abstract available.

8

van den Heuvel-Eibrink MM, Wiemer EA, de Boevere MJ, van der Holt B, Vossebeld PJ, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Blood. 2001 Jun 1;97(11):3605-11. doi: 10.1182/blood.v97.11.3605. Blood. 2001. PMID: 11369657 Free article.

9

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).

van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P. van den Heuvel-Eibrink MM, et al. Leukemia. 2002 May;16(5):833-9. doi: 10.1038/sj.leu.2402496. Leukemia. 2002. PMID: 11986944

10

Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.

van der Sluis IM, van den Heuvel-Eibrink MM, Hählen K, Krenning EP, de Muinck Keizer-Schrama SM. van der Sluis IM, et al. J Pediatr. 2002 Aug;141(2):204-10. doi: 10.1067/mpd.2002.125728. J Pediatr. 2002. PMID: 12183715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

623 results

Search Page

Filters